A Randomized, Evaluator-Blinded, Parallel Group Comparison of PDT With Levulan Topical Solution + Blue Light vs Levulan Topical Solution Vehicle + Blue Light for the Treatment of AK and Reduction of New NMSC in Organ Transplant Recipients.

Trial Profile

A Randomized, Evaluator-Blinded, Parallel Group Comparison of PDT With Levulan Topical Solution + Blue Light vs Levulan Topical Solution Vehicle + Blue Light for the Treatment of AK and Reduction of New NMSC in Organ Transplant Recipients.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2011

At a glance

  • Drugs Aminolevulinic acid (Primary)
  • Indications Actinic keratosis; Skin cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 12 Nov 2010 Planned End Date changed from 1 Sep 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.
    • 12 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top